Physiological and pathological growth hormone secretion

Journal of Pediatric Endocrinology and Metabolism

Volumn 18, Issue 4, 2005, Pages 325-338

  Wajnrajch, Michael P ^a  

^a PFIZER INC   (United States)

Author keywords

Acute lymphoblastic leukemia; Constitutional delay of growth and puberty; Fanconi's anemia; Growth hormone deficiency; Growth hormone neurosecretory dysfunction; Hypothyroidism; Neurosecretory spontaneous overnight growth hormone secretion; Russell Silver syndrome; Small for gestational age

Indexed keywords

GROWTH HORMONE; OXANDROLONE; TESTOSTERONE; THYROID HORMONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; DELAYED PUBERTY; DISEASE ASSOCIATION; FANCONI ANEMIA; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HIGH RISK PATIENT; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; HYPOTHYROIDISM; NEUROSECRETION; PATHOPHYSIOLOGY; PUBERTY; PULSATILE HORMONE RELEASE; REVIEW; SEX DIFFERENCE; SHORT STATURE; SILVER RUSSELL SYNDROME; SMALL FOR DATE INFANT;

EID: 17144363631     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2005.18.4.325     Document Type: Review

References (72)

1. Veldhuis JD, Anderson SM, Shah N, Bray M, Vick T, Gentili A, Mulligan T, Johnson ML, Weltman A, Evans WS, Iranmanesh A. Neurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the human. Growth Horm IGF Res 2001; 11 (Suppl A): S25-27.
2. Albertsson-Wikland K, Rosberg S. Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988; 67: 493-500.
3. Mendlewicz J, Linkowski P, Kerkhofs M, Leproult R, Copinschi G, van Cauter E. Genetic control of 24-hour growth hormone secretion in man: a twin study. J Clin Endocrinol Metab 1999; 84: 856-862.
4. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SD, et al. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993; 123: 215-222.
5. Ranke MB, Guilbaud O, Lindberg A, Cole T. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr 1993; Suppl 391: 82-88.
6. Schönau E, Westermann F, Rauch F, Stabrey A, Wassmer G, Kéller E, Brämswig J, Blum WF. A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency. Eur J Endocrinol 2001; 144: 13-20.
7. Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 2003; 88: 125-131.
8. Zadik Z, Chalew SA, Kowarski A. Assessment of growth hormone secretion in normal stature children using 24-hour integrated concentration of GH and pharmacological stimulation. J Clin Endocrinol Metab 1990; 71: 932-936.
9. Werther GA. Growth hormone measurements versus auxology in treatment decisions: the Australian experience. J Pediatr 1996; 128: S47-51.
10. Werther GA, Wang M, Cowell CT. An auxology-based growth hormone program: update on the Australian experience. J Pediatr Endocrinol Metab 2003; 16 (Suppl 3): 613-618.
11. Albertsson-Wikland K, Isaksson O, Rosberg S, Westphal D. Secretory pattern of growth hormone in children of different growth rates. Acta Endocrinol 1983; 103 (Suppl 256): 72.
12. Hindmarsh P, Smith PJ, Brook CGD, Matthews DR. The relationship between height velocity and growth hormone secretion in short prepubertal children. Clin Endocrinol 1987; 27: 581-591.
13. Diamond FB, Jorgensen EV, Root AW, Shulman DI, Sy JP, Blethen SL, Bercu BB. The role of serial sampling in the diagnosis of growth hormone deficiency. Pediatrics 1998; 102: 521-524.
14. Hindmarsh PC, Matthews DR, Stratton I, Pringle PJ, Brook CGD. Rate of change (modulation) of serum growth hormone concentration is a more important factor in determining growth rate than duration of exposure. Clin Endocrinol (Oxf) 1992; 36: 165-170.
15. Veldhuis JD, Roemmich JN, Rogol AD. Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females-a general clinical research center-based study. J Clin Endocrinol Metab 2003; 85: 2385-2394.
16. Tapanainen P, Rantala H, Leppäluoto J, Lautala P, Käär M-L, Knip M. Nocturnal release of immunoreactive growth hormone-releasing hormone and growth hormone in normal children. Pediatr Res 1989; 26: 404-409.
17. Ehlers CL, Reed TK, Henriksen SJ. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986; 42: 467-474.
18. Linkowski P. Neuroendocrine profiles in mood disorders. Int J Neuropsychopharmacol 2003; 6: 191-197.
19. Nindl BC, Hymer WC, Deaver DR, Kraemer WJ. Growth hormone pulsatility profile characteristics following acute heavy resistance exercise. J Appl Physiol 2001; 91: 163-172.
20. Fanconi G. Familiare infantile perniziosartige Anamie (pernizioses Blutbild und Konstitution). Z Kinderheilkd 1927; 117: 257-280.
21. Potchedly C, Collipp PJ, Wolman SR, Suwansirikul S, Rezvani I. Fanconi's anemia with growth hormone deficiency. J Pediatr 1971; 79: 93-96.
22. Zachmann M, Illig R, Prader A. Fanconi's anemia with isolated growth hormone deficiency. J Pediatr 1972; 80: 159-160.
23. Gleadhill V, Bridges JM, Hadden DR. Fanconi's aplastic anaemia with short stature. Absense of response to human growth hormone. Arch Dis Child 1975; 50: 318-320.
24. Nordon UZ, Humbert JR, MacGillivray MH, Fitzpatrick JE. Fanconi's anemia with growth hormone deficiency. Am J Dis Child 1979; 133: 291-293.
25. Butturini A, Bernasconi S, Izzi G, Gertner JM, Gale RP. Short stature, Fanconi's anaemia, and risk of leukaemia after growth hormone therapy. Lancet 1994; 343: 1576.
26. Wajnrajch MP, Gertner JM, Auerbach AD. Endocrine Disorders in Fanconi Anemia. Fanconi Anemia, Standards of Care. Eugene, OR: Fanconi Anemia Research Foundation, 1999; 23-33.
27. Wajnrajch MP, Gertner JM, Huma Z, Lin K, Verlander PC, Batish SD, Giampietro PF, Davis JG, New MI, Auerbach AD. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744-754.
28. Wajnrajch MP, Rose SR, Petryk A. Endocrine Disorders in Fanconi Anemia. Fanconi Anemia, Standards of Care. Eugene, OR: Fanconi Anemia Research Foundation, 2003; 81-94.
29. van den Berg G, Veldhuis JD, Frölich M, Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenapausal women. J Clin Endocrinol Metab 1996; 81: 2460-2467.
30. Roemmich JN, Clark PA, Mai V, Berr SS, Weltman A, Veldhuis JD, Rogol AD. Alterations in growth and body composition during puberty: III. Influence of maturation, gender, body composition, fat distribution, aerobic fitness, and energy expenditure on nocturnal growth hormone release. J Clin Endocrinol Metab 1998; 83: 1440-1447.
31. Veldhuis JD. Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender. Growth Horm IGF Res 1998; 8 (Suppl B): 49-59.
32. Jansson JO, Frohman LA. Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats. Endocrinology 1987; 120: 1551-1557.
33. Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone. Neuroendocrinology 2003; 77: 380-387.
34. Styne DM. The regulation of pubertal growth. Horm Res 2003; 60 (Suppl 1): 22-26.
35. Miller JD, Esparza A, Wright NM, Garimella V, Lai J, Lester SE, Mosier HD Jr. Spontaneous growth hormone release in term infants: changes during the first four days of life. J Clin Endocrinol Metab 1993; 76: 1058-1062.
36. Shibasaki T, Shizume K, Nakahara M, Masuda A, Kazuko J, Demura H, Wakabayashi I, Ling N. Age-related changes in plasma growth hormone response to growth-hormone-releasing factor in man. J Clin Endocrinol Metab 1984; 58: 212-214.
37. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991; 73: 1081-1088.
38. Russell-Aulet M, Jaffe CA, Demott-Friberg R, Barkan AL. In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging. J Clin Endocrinol Metab 1999; 84: 3490-3497.
39. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984; 251: 2223-2230.
40. Pozo J, Argente J, Barrios V, González-Parra S, Muñoz MT, Hernández H. Growth hormone secretion in children with normal variants of short stature. Horm Res 1994; 41: 185-192.
41. Rogol AD, Breen TJ, Attie KM. National Cooperative Growth Study Substudy II: Do growth hormone levels from serial sampling add important diagnostic information? J Pediatr 1996; 128: S42-46.
42. Tannenbaum GS, Gurd W, Lapointe M. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 1998; 139: 3871-3875.
43. Frohman LA, Kineman RD, Kamegai J, Park S, Teixeira LT, Coschigano KT, Kopchic JJ. Secretagogues and the somatotrope: signaling and proliferation. Rec Prog Horm Res 2000; 55: 269-290.
44. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stovkis-Brantsma WH, Wit J-M. Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 2001; 86: 2459-2464.
45. Roh SG, Nie GY, Loneragan K, Gertler A, Chen C. Direct modification of somatotrope function by long-term leptin treatment of primary cultured ovine pituitary cells. Endocrinology 2001; 142: 5167-5171.
46. Gat-Yablonski G, Ben-Ari T, Shtaif B, Potievsky O, Moran O, Eshet R, Maor G, Segev Y, Phillip M. Leptin reverses the inhibitory effect of caloric restriction on longitudinal growth. Endocrinology 2004; 145: 343-350.
47. Zadik Z, Chalew SA, Kowaraski A. The diagnostic value of integrated growth hormone secretion studies shorter than 24 hours in normal and short-growing children. Horm Res 1992; 38 (Suppl 5-6): 250-255.
48. Aimaretti G, Bellone S, Bellone J, Chiabotto P, Baffoni C, Corneli G, Origlia C, de Sanctis C, Camanni F, Ghigo E. Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction. Clin Endocrinol (Oxf) 2000; 52: 287-293.
49. Chernausek SD, Turner R. Attenuation of spontaneous, nocturnal growth hormone secretion in children with hypothyroidism and its correlation with plasma insulin-like growth factor I concentrations. J Pediatr 1989; 114: 968-972.
50. Buchanan CR, Stanhope R, Adlard P, Jones J, Grant DB, Preece MA. Gonadotrophin, growth hormone and prolactin secretion in children with primary hypothyroidism. Clin Endocrinol (Oxf) 1988; 29: 427-436.
51. Blatt J, Bercu BB, Gillin C, Mendelson WB, Poplack DG. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr 1984; 104: 182-186.
52. Hata M, Ogino I, Aida N, Saito K, Omura M, Kigasawa H, Toyoda Y, Tachibana K, Matsubara S, Inoue T. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer 2001; 96 (Suppl): 117-124.
53. Leung W, Rose SR, Zhou Y, Hancock ML, Burstein S, Schriock EA, Lustig R, Danish RK, Evans WE, Hudson MM, Pui CH. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 2002; 20: 2959-2964.
54. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002; 87: 3136-3141.
55. Arrigo T, Cisternino M, De Luca F, Saggese G, Messina MF, Pasquino AM. Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. J Pediatr Endocrinol Metab 1996; 9: 511-517.
56. Albanese A, Stanhope R. Predictive factors in the determination of final height in boys with constitutional delay of growth and puberty. J Pediatr 1995; 126: 545-550.
57. Kerrigan JR, Martha PMJ, Veldhuis JD, Blizzard RM, Rogol AD. Altered growth hormone secretory dynamics in prepubertal males with constitutional delay of growth. Pediatr Resh 1993; 33: 278-283.
58. Albertsson-Wikland K, Boguszewski M, Karlberg J. Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res 1998; 49 (Suppl 2): 7-13.
59. Blissett J, Harris G, Kirk J. Effect of growth hormone therapy on feeding problems and food intake in children with growth disorders. Acta Paediatr 2000; 89: 644-649.
60. Blissett J, Harris G, Kirk J. Feeding problems in Silver-Russell syndrome. Dev Med Child Neurol 2001; 43: 39-44.
61. Silver HK, Kiyasu W, George J, Deamer WC. Syndrome of congenital hemihypertrophy, shortness of stature and elevated urinary gonadotrophins. Pediatrics 1953; 12: 368-375.
62. Ackland FM, Stanhope R, Eyre C, Hamill G, Jones J, Preece MA. Physiological growth hormone secretion in children with short stature and intra-uterine growth retardation. Horm Res 1988; 30: 241-245.
63. Albertsson-Wikland K. Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Swedish Paediatric Study Group for Growth Hormone Treatment. Acta Paediatr Scand 1989; Suppl 349: 35-41.
64. Stanhope R, Ackland F, Hamill G, Clayton J, Jones J, Preece MA. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation. Acta Paediatr Scand 1989: Suppl 349: 47-52.
65. Joenje H, Oostra AB, Wijker M, di Summa FM, van Berkel CG, Rooimans MA, Ebell W, van Weel M, Pronk JC, Buchwald M, Arwert F. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61: 940-944.
66. Auerbach AD, Adler B, Chaganti RSK. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics 1981; 67: 128-135.
67. Auerbach AD. Fanconi anemia: genetic testing in Ashkenazi Jews. Genetic Testing 1997; 1: 27-33.
68. Ross JL, Long LM, Loriaux DL, Cutler GBJ. Growth hormone secretory dynamics in Turner syndrome. J Pediatr 1985; 106: 202-206.
69. Albertsson-Wikland K, Hall K. Growth hormone treatment in short children: relationship between growth and serum insulin-like growth factor I and II levels. J Clin Endocrinol Metab 1987; 65: 671-678.
70. Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, Schroter W. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr 1997; 156: 777-783.
71. Rogol AD, Blethen SL, Sy JP, Veldhuis JD. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy? Clin Endocrinol (Oxf) 2003; 58: 229-237.
72. Shehadeh N, Hazani A, Rudolf MC, Peleg I, Benderly A, Hochberg Z. Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr Scand 1990; 79: 790-795.